Libbe Englander

Libbe Englander is the CEO and Founder of Pharm3r, a healthcare analytics company focusing on improving client outcomes. Libbe also serves on the Robertson Therapeutic Development Fund Review Committee at Rockefeller University. Previously, Libbe worked as a Principal at CCHScience and as the Managing Partner at NextStep Capital, focusing on venture capital funding of early stage healthcare companies. With a Ph.D. in Molecular Biology from The Rockefeller University and a B.S. in Biology from Yale University, Libbe has a strong background in the healthcare industry.